These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
94 related articles for article (PubMed ID: 9677458)
1. Escalating dose of oral ondansetron in the prevention of radiation induced emesis. Maisano R; Pergolizzi S; Settineri N Anticancer Res; 1998; 18(3B):2011-3. PubMed ID: 9677458 [TBL] [Abstract][Full Text] [Related]
2. [Ondansetron in the prevention of radiation-induced nausea and emesis in patients treated with single-fraction irradiation]. Jeremić B Srp Arh Celok Lek; 1996; 124(5-6):131-4. PubMed ID: 9102832 [TBL] [Abstract][Full Text] [Related]
3. Double-blind comparative trial of oral ondansetron versus oral granisetron versus IV ondansetron in the prevention of nausea and vomiting associated with highly emetogenic preparative regimens prior to stem cell transplantation. Fox-Geiman MP; Fisher SG; Kiley K; Fletcher-Gonzalez D; Porter N; Stiff P Biol Blood Marrow Transplant; 2001; 7(11):596-603. PubMed ID: 11760147 [TBL] [Abstract][Full Text] [Related]
4. Comparison of the efficacy and safety of oral granisetron plus dexamethasone with intravenous ondansetron plus dexamethasone to control nausea and vomiting induced by moderate/severe emetogenic chemotherapy. Chiou TJ; Tzeng WF; Wang WS; Yen CC; Fan FS; Liu JH; Chen PM Zhonghua Yi Xue Za Zhi (Taipei); 2000 Oct; 63(10):729-36. PubMed ID: 11076429 [TBL] [Abstract][Full Text] [Related]
6. Efficacy of ondansentron treatment for acute emesis with different dosing schedules 8 vs 32 mg. A randomized study. Tsavaris N; Kosmas CH; Vadiaka M; Kontos A; Katsorida M; Dimitrakopoulos A; Zerai A; Koufos CH J Exp Clin Cancer Res; 2001 Mar; 20(1):29-34. PubMed ID: 11370826 [TBL] [Abstract][Full Text] [Related]
7. 5-hydroxytryptamine-3 receptor antagonist with or without short-course dexamethasone in the prophylaxis of radiation induced emesis: a placebo-controlled randomized trial of the National Cancer Institute of Canada Clinical Trials Group (SC19). ; Wong RK; Paul N; Ding K; Whitehead M; Brundage M; Fyles A; Wilke D; Nabid A; Fortin A; Wilson D; McKenzie M; Ackerman I; Souhami L; Chabot P; Pater J J Clin Oncol; 2006 Jul; 24(21):3458-64. PubMed ID: 16849762 [TBL] [Abstract][Full Text] [Related]
8. [The use of granisetron per os in radiotherapy-induced emesis]. Krengli M; Lazzari R; Manara M Minerva Med; 1996 Dec; 87(12):605-8. PubMed ID: 9064597 [TBL] [Abstract][Full Text] [Related]
9. Prevention of cisplatin-induced acute and delayed emesis by the selective neurokinin-1 antagonists, L-758,298 and MK-869. Van Belle S; Lichinitser MR; Navari RM; Garin AM; Decramer ML; Riviere A; Thant M; Brestan E; Bui B; Eldridge K; De Smet M; Michiels N; Reinhardt RR; Carides AD; Evans JK; Gertz BJ Cancer; 2002 Jun; 94(11):3032-41. PubMed ID: 12115394 [TBL] [Abstract][Full Text] [Related]
10. Establishing the dose of the oral NK1 antagonist aprepitant for the prevention of chemotherapy-induced nausea and vomiting. Chawla SP; Grunberg SM; Gralla RJ; Hesketh PJ; Rittenberg C; Elmer ME; Schmidt C; Taylor A; Carides AD; Evans JK; Horgan KJ Cancer; 2003 May; 97(9):2290-300. PubMed ID: 12712486 [TBL] [Abstract][Full Text] [Related]
11. A randomized, double-blind, multicenter trial comparing transdermal scopolamine plus ondansetron to ondansetron alone for the prevention of postoperative nausea and vomiting in the outpatient setting. Gan TJ; Sinha AC; Kovac AL; Jones RK; Cohen SA; Battikha JP; Deutsch JS; Pergolizzi JV; ; Glass PS Anesth Analg; 2009 May; 108(5):1498-504. PubMed ID: 19372328 [TBL] [Abstract][Full Text] [Related]
12. Intravenous ondansetron plus intravenous dexamethasone with different ondansetron dosing schedules during multiple cycles of cisplatin-based chemotherapy. Chen PT; Liaw CC Chang Gung Med J; 2008; 31(2):167-74. PubMed ID: 18567417 [TBL] [Abstract][Full Text] [Related]
13. A comparison of oral ondansetron syrup or intravenous ondansetron loading dose regimens given in combination with dexamethasone for the prevention of nausea and emesis in pediatric and adolescent patients receiving moderately/highly emetogenic chemotherapy. White L; Daly SA; McKenna CJ; Zhestkova N; Leal C; Breatnach F; Smelhaus V; Hung IJ; Kowalczyk J; Ninane J; Mitchell T; Haigh C Pediatr Hematol Oncol; 2000 Sep; 17(6):445-55. PubMed ID: 10989464 [TBL] [Abstract][Full Text] [Related]
14. Clinical studies with ondansetron in the control of radiation-induced emesis. Priestman TJ Eur J Cancer Clin Oncol; 1989; 25 Suppl 1():S29-33. PubMed ID: 2533896 [TBL] [Abstract][Full Text] [Related]
15. Efficacy of an ondansetron orally disintegrating tablet: a novel oral formulation of this 5-HT(3) receptor antagonist in the treatment of fractionated radiotherapy-induced nausea and emesis. Emesis Study Group for the Ondansetron Orally Disintegrating Tablet in Radiotherapy Treatment. LeBourgeois JP; McKenna CJ; Coster B; Feyer P; Franzén L; Goedhals L; Marzecki Z; Souhami L; Stewart A; Tønnessen F; Haigh C; Mitchell T; Wilkinson JR; Graham E Clin Oncol (R Coll Radiol); 1999; 11(5):340-7. PubMed ID: 10591823 [TBL] [Abstract][Full Text] [Related]
16. The antiemetic efficacy of oral ondansetron plus intravenous dexamethasone in patients with gynecologic malignancies receiving carboplatin-based chemotherapy. Markman M; Kennedy A; Webster K; Peterson G; Kulp B; Belinson J Gynecol Oncol; 2000 Jul; 78(1):43-6. PubMed ID: 10873408 [TBL] [Abstract][Full Text] [Related]
17. A double-blind, randomised, parallel group, multinational, multicentre study comparing a single dose of ondansetron 24 mg p.o. with placebo and metoclopramide 10 mg t.d.s. p.o. in the treatment of opioid-induced nausea and emesis in cancer patients. Hardy J; Daly S; McQuade B; Albertsson M; Chimontsi-Kypriou V; Stathopoulos P; Curtis P Support Care Cancer; 2002 Apr; 10(3):231-6. PubMed ID: 11904788 [TBL] [Abstract][Full Text] [Related]
18. Double-blind, randomized, parallel-group study on the efficacy and safety of oral granisetron and oral ondansetron in the prophylaxis of nausea and vomiting in patients receiving hyperfractionated total body irradiation. Spitzer TR; Friedman CJ; Bushnell W; Frankel SR; Raschko J Bone Marrow Transplant; 2000 Jul; 26(2):203-10. PubMed ID: 10918432 [TBL] [Abstract][Full Text] [Related]
19. [Examination on efficacy and safety of concurrent use of ondansetron hydrochloride and steroid in gynecological cancer patients on cisplatin]. Eguchi F; Taguchi T; Furue H; Ikeda M; Tsukakoshi S; Gan To Kagaku Ryoho; 2001 Oct; 28(10):1423-9. PubMed ID: 11681251 [TBL] [Abstract][Full Text] [Related]
20. Randomized, double-blind, dose-finding study of dexamethasone in preventing acute emesis induced by anthracyclines, carboplatin, or cyclophosphamide: Italian Group For Antiemetic Research J Clin Oncol; 2004 Feb; 22(4):725-9. PubMed ID: 14966097 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]